Population pharmacokinetics of raxibacumab in healthy adult subjects.
Sign Up to like & getrecommendations! Published in 2021 at "British journal of clinical pharmacology"
DOI: 10.1111/bcp.14894
Abstract: AIM Raxibacumab is a fully humanized monoclonal antibody that blocks the interaction of Bacillus anthracis toxins, thereby protecting target cells from its effects. Raxibacumab is approved in the USA for the treatment of adults and… read more here.
Keywords: healthy adult; pharmacokinetics raxibacumab; raxibacumab; population pharmacokinetics ... See more keywords